Skip to main content
. 2020 Aug 27;12(9):2428. doi: 10.3390/cancers12092428

Figure 1.

Figure 1

Current serum proteomics workflows for the discovery, verification, and validation of cancer biomarkers. Top panel: global comparative serum proteomics workflow for screening some candidates of protein signature from tens/hundreds of differentially expressed proteins found between healthy and cancer patients. Middle panel: targeted quantitative serum proteomic workflow in a larger number of samples for verifying potential biomarker candidates. Bottom panel: the development of an immunoassay for selected potential biomarkers for validation and clinical application.